Biotech

New Preclinical Study Shows Immunovaccine's DepoVax(TM)-Based Cancer Vaccine May Improve Efficacy of Checkpoint Inhibitors

HALIFAX, NOVA SCOTIA: Data Presented at AACR Annual Meeting 2016 Show Control of Cancer Growth in Advanced Tumors Previously Non-Responsive to Treatment with PD-1 Blockades Alone ...

Hemostemix Receives IRB Approval from the Houston Methodist Hospital Research Institute and the University of California Los Angeles

TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 04/18/16 -- Hemostemix Inc. ("Hemostemix" or the "Company") (TSX VENTURE: HEM)(OTCQX: HMTXF), a clinical-stage autologous cell-therapy company ...

Ceapro Inc. Provides 2015 Business Highlights and 2016 Business Outlook

EDMONTON, ALBERTA: - Ceapro expects to commence clinical program with avenanthramides as anti-inflammatory compound before year end - - Pilot clinical study to develop beta glucan as a cholesterol reducer expected to i ...

Titan Pharmaceuticals Announces Presentation of Probuphine Phase 3 Data at American Society of Addiction Medicine Annual Conference

SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 04/15/16 -- (NASDAQ: TTNP) announced today the presentation of data from the last Phase 3 study of Probuphine®, a six month subdermal buprenorphine impla ...

Kadmon to Present Preclinical Data Demonstrating That Its Novel Immuno-Oncology Compound Achieves Long-Lasting and Persistent Antitumor Immunity

NEW YORK, NY: Data to Be Presented at AACR Annual Meeting ...

Ceapro Inc. Reports 2015 Financial Results, Best Financial Year in Company's History

EDMONTON, ALBERTA: Ceapro posts highest revenues, profits and cash flows reported in Company's history for both Q4 2015 and FY 2015 ...

Immunovaccine Names Frederic Ors Chief Executive Officer; Andy Sheldon, Medicago CEO, to Join Board of Directors

HALIFAX, NOVA SCOTIA: HALIFAX, NOVA SCOTIA -- (Marketwired) -- 04/13/16 -- Immunovaccine Inc. ("Immunovaccine" or the "company") (TSX: IMV)(OTCQX: IMMVF), a clinical stage vaccine and immunotherapy co ...

Soricimed Announces Presentations at the Upcoming American Association of Cancer Research (AACR) Annual Meeting

TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 04/12/16 -- Soricimed Biopharma Inc. ("Soricimed"), a clinical-stage pharmaceutical company discovering and developing peptide-based cancer therapeutic ...

Immunovaccine to Present New Pre-Clinical Data at the 2016 AACR Annual Meeting

HALIFAX, NOVA SCOTIA: Study Examines Potential Anti-Cancer Effects of Combining Checkpoint Inhibitors with Company's DepoVax(TM) (DPX)-based Vaccine Platform ...

VIBATIV(R) (Telavancin) Shows Greater In Vitro Potency Against Difficult-to-Treat Pathogens Causing Hospital-Acquired Bacterial Pneumonia, Including MRSA, Compared to Alternative Antibiotic Treatments

DUBLIN, IRELAND: Data Presentation at 2016 ECCMID Conference Demonstrates Potent In Vitro Activity for VIBATIV(R) Against 100% of Evaluated Staphylococcus Aureus Clinical Isolates, Regardless of Type or Resistance Pro ...